Bhagawati Oxygen (BSE 509449)₹36.18+1.37%Commodity Chemicals
In the Mar 2026 quarter (standalone), Bhagawati Oxygen reported sales of ₹0 Cr and net profit of ₹3.25 Cr, up 2,400.0% year on year. For the year to Mar 2026, sales were ₹0.48 Cr and net profit ₹3.26 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.30 | 0.22 | 0.02 | 0.15 | 0.23 | 0.30 | 0.25 | 0.00 | 0.14 | 0.28 | 0.04 | 0.00 |
| Expenses | 0.78 | 2.21 | 0.58 | 2.00 | 0.49 | 0.57 | 0.57 | 0.37 | 0.42 | 0.44 | 0.39 | 0.45 |
| Operating Profit | −0.47 | −1.98 | −0.55 | −1.84 | −0.25 | −0.26 | −0.31 | −0.36 | −0.27 | −0.15 | −0.34 | −0.44 |
| OPM % | −154.8% | −865.2% | −1,866.7% | −1,156.2% | −108.3% | −87.1% | −123.1% | −3,700.0% | −186.6% | −55.2% | −700.0% | −4,500.0% |
| Other Income | 0.00 | 6.44 | 0.05 | −0.10 | 0.12 | 0.13 | 0.17 | 0.49 | 0.29 | 0.31 | 0.31 | 3.82 |
| Interest | 0.15 | 0.14 | 0.06 | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.42 | 0.12 | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
| Profit before tax | −1.06 | 4.19 | −0.62 | −1.98 | −0.20 | −0.20 | −0.21 | 0.08 | −0.04 | 0.13 | −0.08 | 3.35 |
| Tax % | −4.7% | 13.4% | −13.1% | −13.7% | 0.0% | 5.3% | 5.0% | −100.0% | 33.4% | 8.4% | 14.3% | 2.1% |
| Net Profit | −0.98 | 3.62 | −0.51 | −1.70 | −0.19 | −0.18 | −0.20 | 0.13 | −0.02 | 0.10 | −0.07 | 3.25 |
| EPS (Rs) | −4.27 | 15.67 | −2.24 | −7.37 | −0.85 | −0.81 | −0.90 | 0.60 | −0.12 | 0.47 | −0.34 | 14.06 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 10.19 | 9.98 | 8.44 | 7.63 | 2.99 | 0.39 | 1.06 | 0.67 | 0.71 | 0.80 | 0.48 | 0.46 |
| Expenses | 9.53 | 8.61 | 6.51 | 6.58 | 3.62 | 1.70 | 2.16 | 1.91 | 5.51 | 2.01 | 1.72 | 1.70 |
| Operating Profit | 0.67 | 1.38 | 1.93 | 1.05 | −0.62 | −1.30 | −1.09 | −1.23 | −4.78 | −1.20 | −1.23 | −1.20 |
| OPM % | 6.6% | 13.9% | 23.0% | 13.8% | −21.0% | −327.5% | −102.8% | −182.3% | −666.7% | −149.4% | −253.1% | −260.9% |
| Other Income | 0.49 | 0.76 | 1.25 | 0.65 | 2.94 | 0.48 | 0.61 | 1.03 | 6.40 | 0.88 | 4.69 | 4.73 |
| Interest | 0.02 | 0.20 | 0.75 | 0.83 | 0.60 | 0.56 | 0.70 | 0.72 | 0.49 | 0.12 | 0.04 | 0.01 |
| Depreciation | 0.24 | 0.43 | 1.87 | 1.87 | 1.86 | 1.85 | 1.80 | 1.67 | 0.55 | 0.05 | 0.05 | 0.08 |
| Profit before tax | 0.91 | 1.52 | 0.57 | −1.01 | −0.17 | −3.26 | −3.01 | −2.62 | 0.56 | −0.52 | 3.36 | 3.36 |
| Tax % | 24.5% | 32.5% | 26.9% | −4.0% | −62.4% | −4.6% | −6.0% | −7.3% | 25.5% | −11.7% | 2.4% | — |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.99 | 5.98 | 0.00 | 0.00 | — |
| Net Profit | 0.66 | 1.01 | 0.40 | −0.95 | −0.05 | −3.09 | −2.81 | −2.41 | 0.40 | −0.44 | 3.26 | 3.26 |
| EPS (Rs) | 2.89 | 4.40 | 1.76 | −4.14 | −0.25 | −13.39 | −12.18 | −10.44 | 1.76 | −1.94 | 14.11 | 14.07 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 2.30 | 2.30 | 2.30 | 2.30 | 2.30 | 2.30 | 2.30 | 2.30 | 2.30 | 2.30 | 2.30 | 2.30 |
| Reserves | 8.78 | 9.44 | 10.42 | 10.80 | 9.81 | 10.16 | 6.91 | 4.36 | 1.88 | 2.20 | 1.67 | 4.96 |
| Borrowings | 0.34 | 0.74 | 13.46 | 12.61 | 8.90 | 5.92 | 6.77 | 7.51 | 6.42 | 1.31 | 1.60 | 1.05 |
| Other Liabilities | 3.25 | 2.70 | 3.57 | 1.96 | 1.60 | 1.52 | 1.76 | 1.56 | 2.87 | 5.51 | 5.54 | 2.07 |
| Total Liabilities | 14.67 | 15.18 | 29.75 | 27.67 | 22.61 | 19.90 | 17.74 | 15.73 | 13.47 | 11.32 | 11.11 | 10.38 |
| Fixed Assets | 2.13 | 2.14 | 16.27 | 14.40 | 12.55 | 10.70 | 8.85 | 7.07 | 5.27 | 1.46 | 1.41 | 1.53 |
| CWIP | 0.00 | 0.34 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 2.45 | 2.24 | 2.39 | 2.02 | 2.00 | 1.94 | 2.17 | 1.98 | 0.74 | 0.82 | 1.08 | 1.71 |
| Other Assets | 10.09 | 10.46 | 11.09 | 11.25 | 8.06 | 7.26 | 6.72 | 6.68 | 7.46 | 9.04 | 8.62 | 7.14 |
| Inventories | 1.26 | 0.42 | 0.17 | 0.10 | 0.17 | 0.09 | 0.05 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 |
| Trade receivables | 3.58 | 2.85 | 3.50 | 1.95 | 1.29 | 3.05 | 2.48 | 2.87 | 3.15 | 2.93 | 2.74 | 0.12 |
| Cash & equivalents | 4.13 | 4.19 | 4.39 | 6.13 | 4.10 | 2.12 | 1.97 | 1.58 | 1.26 | 0.66 | 0.56 | 1.29 |
| Total Assets | 14.67 | 15.18 | 29.75 | 27.67 | 22.61 | 19.90 | 17.74 | 15.73 | 13.47 | 11.32 | 11.11 | 10.38 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | −0.31 | −0.19 | 1.40 | 0.68 | 4.14 | 3.20 | −0.73 | −0.43 | 0.32 | −4.23 | −0.57 | 0.37 |
| Cash from investing activity | 0.40 | 0.08 | −13.94 | 0.85 | 0.41 | 0.34 | 0.06 | 0.59 | 2.24 | 9.13 | 0.38 | 0.23 |
| Cash from financing activity | 0.14 | 0.16 | 12.61 | −1.54 | −4.53 | −3.61 | 0.66 | −0.16 | −1.95 | −5.54 | 0.15 | −0.60 |
| Net cash flow | 0.25 | 0.05 | 0.03 | 0.00 | 0.01 | −0.05 | 0.00 | 0.00 | 0.60 | −0.61 | 0.00 | 0.00 |
| Capex | 0.03 | 0.26 | 14.22 | 0.02 | 0.00 | 0.00 | 0.00 | 0.02 | 0.02 | 0.02 | 0.00 | 0.19 |
| Free cash flow | −0.31 | −0.77 | −12.78 | 0.67 | 4.14 | 3.20 | −0.71 | −0.42 | 1.17 | 4.83 | −0.57 | 0.17 |
| CFO / OP % | −2.0% | 24.0% | 102.0% | 58.1% | 390.1% | −506.0% | 55.1% | 67.0% | −24.9% | 88.1% | 46.0% | −29.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 110 | 100 | 126 | 83 | 60 | 369 | 2,253 | 975 | 1,684 | 1,479 | 1,229 | 81 |
| Inventory days | 59 | 23 | 10 | 52 | 43 | 107 | 364 | 14 | 28 | 23 | 18 | — |
| Days payable | 101 | 97 | 133 | 330 | 85 | 446 | 3,650 | 441 | 832 | 918 | 740 | — |
| Cash conversion cycle | 72 | 30 | 6 | −192 | 21 | 33 | −1,030 | 551 | 883 | 586 | 511 | 83 |
| Working capital days | 72 | 103 | −212 | −337 | −62 | 181 | 1,379 | 311 | −724 | 696 | 159 | −1,317 |
| ROCE % | 12.5% | 7.3% | 8.2% | 4.7% | −0.7% | 2.2% | −15.6% | −15.5% | −21.5% | −57.6% | −6.7% | 49.0% |
For the Mar 2026 quarter, Bhagawati Oxygen reported sales of ₹0 Cr and net profit of ₹3.25 Cr, up 2,400.0% year on year. The operating margin was −4,500.0%.
Bhagawati Oxygen's sales for the year to Mar 2026 were ₹0.48 Cr; over the last twelve months they were ₹0.46 Cr.
Net profit for the year to Mar 2026 was ₹3.26 Cr, and ₹3.26 Cr over the last twelve months. Earnings per share over the same trailing period were ₹14.07.
Bhagawati Oxygen reported borrowings of ₹1.05 Cr at Mar 2026, against cash and equivalents of ₹1.29 Cr.
Cash from operations was ₹0.37 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹0.17 Cr.